Search our site RxMed


Valuable information for over 200 common illnesses
Patient Illnesses
Pharmaceutical Information
Travel Illness Info
About RxMed
Our Medical Advisory Board
General Illness Information

Common Name:

Hyperlipidemia, Hypercholesterolemia

Medical Term:

Hyperlipidemia
Description:

Abnormally high levels of fat in the blood.

Serum cholesterol higher than 200 mg/dL (5.18 mmol/L). 

High risk: Serum cholesterol higher than 240 mg/dL (6.22 mmol/L)

High density lipoprotein fraction of cholesterol (HDL) is protective ["Good Cholesterol"]

Low density lipoprotein (LDL) is  atherogenic ["bad cholesterol"] 

This is a serious and "silent" problem in North America-

120 million people with cholesterol 200 mg/dL (5.18 mmol/L) or more, 60 million with 240 mg/dL (6.22 mmol/L) or more.

 

 

 

Causes: Primary:

Diet

 Heredity

 Obesity

 Sedentary life-style

 Stress

Secondary to other disorders:

Hypothyroidism

Diabetes mellitus

Nephrotic syndrome

Obstructive liver disease

Progestins

Anabolic steroids

Diuretics except indapamide.

Beta blockers except those with intrinsic sympathomimetic activity (ISA)

Some immunosuppressants.

 

Prevention:

Eat a diet that is low in fat.

Exercise regularly.

If you have diabetes, adhere closely to your treatment program.

Get a medical test to check your blood level of cholesterol and its fractions.

 

Signs & Symptoms
Corneal arcus (whitish ring around the pupil) before 50

Xanthomata, Xanthelasma ( fat deposits on eyelids, face).

Arterial bruits ( loud arterial sounds, denote arterial narrowing)

Claudication ( pain in extremity, on minimal exertion)

Angina pectoris

Stroke

Myocardial infarction (Heart attack). 

 

Risk Factors

Obesity

 Heredity

Sedentary lifestyle

Lack of exercise.

 

Diagnosis & Treatment

For diagnosis, a laboratory blood study to measure blood lipids.  The patient must be fasting at least 10 hours to obtain a valid lipid level.

Consumption of caffeine prior to the test may increase the cholesterol level. 

General Measures:
Requires intervention: HDL less than 35 mg/dL (0.78 mmol/L), LDL greater than 160 mg/dL (4.14 mmol/L)
Recently, LDL acceptable levels have been lowered by the American Heart Association, and these are being correlated with cardiac risk factors of diabetes, hypertension, coronary event, smoking, peripheral vascular disease, severe obesity, strong family history, to initiate treatment early.
Medications:
Drugs of choice are a class of drugs termed as "statins":

Fluvastatin (Lescol), lovastatin (Mevacor), pravastatin (Pravachol), 20-40 mg per day, or cerivastatin (Baycol) 0.3-0.4 mg taken in evening. Effects: 20-40% LDL decrease, decreases triglycerides.

Simvastatin (Zocor) 5-80 mg may decrease LDL 50%, raise HDL, lower triglycerides

Atorvastatin (Lipitor)10-80 mg may be taken any time of day, may decrease LDL 60%, also raises HDL and lowers triglycerides

 

Liver function must be checked periodically.

 

Activity:
No restrictions
Diet:
A diet low in fats is mandatory.

Reduce all dietary fats. Olive oil should be preferentially used.

Increase fiber, increase intake of fruits, vegetables, whole grains, and garlic

Emphasize, vegetarian, meatless, egg less, cheese-less meals, with poultry, fish, and nonfat milk or yogurt

Minimal daily alcohol use may increase HDL

Dietary adherence to low fat and cholesterol generally may be expected to result in a 10% LDL reduction

Intake of too many carbohydrates with a high glycemic index, e.g., bread rice, pasta, potatoes, will make weight loss and cholesterol reduction more difficult.

Possible Complications :
Coronary heart disease, cerebrovascular disease, generalized arteriosclerosis.
Prognosis

1% decrease in cholesterol results in 2% decreased risk of coronary heart disease

Primary prevention of coronary artery disease is very important, and includes dramatic reduction of LDL cholesterol, and modification of all the coronary risk factors:

Diabetes, hypertension,  previous coronary event, smoking, peripheral vascular disease, severe obesity.

If treatment as above initiated early, with complete compliance, risk of coronary event can be reduced dramatically.